Dichlorotetra-mu-Isobutyratodirhenium(III): enhancement of cisplatin action and RBC-stabilizing properties.

Abstract

A novel antitumor system including the use of a cluster rhenium compound and cisplatin is presented. Enhancement of cisplatin action and antitumor properties of rhenium compound initially took place due to the properties of quadruple metal-to-metal bond between two atoms of rhenium.